Browse, search and watch Biotechnology audio, videos and more at WWL Radio.
Jason Hawes & JV Johnson talk with journalist Annie Jacobsen about her books that detail many secret government programs including - Operation Paperclip, DARPA, Area 51, and much more. ANnie has talked to the people who have been directly involved in these clandestine operations, and programs and she reveals their intent, their scale and their effectiveness. 5/3/2017 - Beyond Reality Radio with Jason Hawes & JV Johnson
Jason Hawes & JV Johnson talk with Actress, Author Paige McKenzie about her role in the development and the popularization of the Sunshine Girl series. Starting as a series of YouTube videos and becoming 3 best-selling books, and soon a TV show, these paranormal-themed shows are quickly becoming a phenomenon. 4/13/2017 - Beyond Reality Radio with Jason Hawes & JV Johnson
could help those firms. They've especially targeted his acquisition of shares in Innate Immunotherapeutics, an Australian biotech firm that's said Price got a special insider's deal. Price, who has said he learned of the opportunity from a fellow
remarking in 2005 that he enjoyed shooting people. He also drew more recent scrutiny for his involvement with the embattled biotech company Theranos, where he serves on the board. Born in Pullman, Washington, Mattis enlisted in the Marine Corps in 1969
investigation of a Christie donor who received a fake law enforcement ID badge. That donor founded Celgene, the New Jersey biotech firm Bagger left the Christie administration to work for. As part of his lobbying job for the company, Bagger also accompanied
together who work across a variety of industries, like ocean technology, fisheries and fish processing, and sectors like biotechnology and ocean tourism. The result: More of the fish yield is being used for different purposes, generating new revenue and diversifying
excited Sanofi will seek to develop this treatment to other cancers. He says it takes hundreds of millions of dollars for biotechnology companies to bring a new drug to the market and hopefully Sanofi will have success. "There's no guarantee they will